Playback speed
10 seconds
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis: Study Review
By
National Jewish Health
FEATURING
Charles Daley
By
National Jewish Health
FEATURING
Charles Daley
309 views
October 5, 2021
Charles Daley, MD, of National Jewish Health, discusses the article “Phase 2 Trial of the ...
read more ↘ DPP-1 Inhibitor Brensocatib in Bronchiectasis” during the 30-minute webinar of the NTM Journal Club on September 28, 2021. Article summary link: https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/ntm-article-summary-dpp-1-inhibitor-brensocatib_vol1_issue2.aspx
↖ read less
read more ↘ DPP-1 Inhibitor Brensocatib in Bronchiectasis” during the 30-minute webinar of the NTM Journal Club on September 28, 2021. Article summary link: https://www.nationaljewish.org/education/pro-ed/live-events/national-jewish-health-journal-clubs/pdfs/ntm-article-summary-dpp-1-inhibitor-brensocatib_vol1_issue2.aspx
↖ read less
Comments 0
Login to view comments.
Click here to Login